A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...

In many cases, it's not until memory problems start creeping up that most people learn they have Alzheimer's disease. By then, the disease may already be progressing, leaving limited options for ...

The problems of accuracy, privacy, and access to follow-up care mean the new diagnostics available online fall short of an ...

A groundbreaking new study shows that artificial intelligence can help detect Alzheimer’s disease and other dementias ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of when the ...

A simple blood test for platelet activity at middle age could one day help identify people at risk for Alzheimer's disease ...

Mayo Clinic scientists have developed a new method to predict Alzheimer's risk decades before symptoms appear, using brain scans and genetics to estimate a 10-year likelihood.